MHRA Safety Roundup: July 2026

Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. This roundup provides a summary of their latest safety advice for medicines and medical device users. It includes details of medicine recalls, medical device field safety notices and details of how to report drug reactions and device incidents.

Content

This month's Safety Roundup includes: 

• Drug Safety Update on Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulism.
• Drug Safety Update on Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension.
• Letters, medicines recalls and device notifications sent to healthcare professionals in July 2026 .
• News and guidance on:
• Immune checkpoint inhibitors: product information updated to include myocarditis-myositis-myasthenia gravis overlap syndrome
• Bladder anticholinergics: review of risk of dementia.